Does the impact of COVID-19 on patients with systemic sclerosis change over time?
Elisabeth DeibelPatricia E CarreiraMadelon C VonkNicoletta Del PapaRadim BečvářAlfredo Guillén-Del-CastilloCampochiaro CorradoHadi PoormoghimSophie I E LiemMaria-Grazia LazzaroniAlessandro GiolloArsenne MekinianJeska de Vries-BouwstraMaria De SantisAlexandra Balbir-GurmanCarmen-Marina MihaiGiacomo DE LucaSergey MoiseevElisabetta ZanattaRosario FotiSimona RednicChristopher P DentonMaurizio CutoloLaura BelloliPaolo AiroLiudmila GarzanovaGianluca MoronciniMurat İnançStylianos PanopoulosJose-Luis TandaipanEmmanuel ChatelusEdoardo RosatoMasataka KuwanaSule YavuzJuan J Alegre-SanchoVanessa SmithGabriella SzűcsJoerg Christoph HenesIgnasi Rodríguez-PintóFabiola AtzeniJulia SpieringsMarie-Elise TruchetetMarcin MilchertDaniel Brito de AraujoGabriela RiemekastenVera BernardinoThierry MartinFrancesco Del GaldoAlessandra VaccaFabian MendozaØyvind MidtvedtGiuseppe MurdacaTânia SantiagoVeronica CodulloFabio CacciapagliaUlrich WalkerCathrine BrunborgFrancesca TirelliYannick AllanoreDaniel E FurstMarco MatucciArmando GabrielliAnastasiia KozlovaAnna-Maria Hoffmann-VoldPublished in: Arthritis care & research (2023)
Outcome of SSc patients with COVID-19 improved significantly over time, due to intrinsic and extrinsic factors. This article is protected by copyright. All rights reserved.